Table 4.
Countries with seven or more publications in research on the application of nanomedicine in the antileishmanial field.
| Country | TP | Contribution Rate (%) | TC | Average Citations per Document |
|---|---|---|---|---|
| Iran | 98 | 18.70% | 1802 | 18.39 |
| Brazil | 96 | 18.32% | 1754 | 18.27 |
| India | 80 | 15.26% | 2110 | 26.38 |
| Pakistan | 53 | 10.11% | 1654 | 31.21 |
| United States | 20 | 3.82% | 822 | 41.10 |
| Spain | 17 | 3.24% | 393 | 23.12 |
| France | 15 | 2.86% | 452 | 30.13 |
| Turkey | 12 | 2.29% | 235 | 19.58 |
| Iraq | 11 | 2.10% | 105 | 9.55 |
| Italy | 10 | 1.91% | 440 | 44.00 |
| Saudi Arabia | 9 | 1.72% | 186 | 20.67 |
| Greece | 8 | 1.53% | 184 | 23.00 |
| Portugal | 7 | 1.34% | 120 | 17.14 |
| Germany | 7 | 1.34% | 1528 | 218.29 |
Abbreviations available in Table 3.